September 29, 2010

Cybiocare announces the appointment
of Mr. Desmarais as Regulatory Affairs Advisor

Cybiocare the leading developer of non-invasive photonic medical devices, today announced that Mr. Jean-Pierre Desmarais has been appointed to the position of Regulatory Affairs Advisor.

In his new role, Mr. Desmarais will oversee Cybiocare’s regulatory affairs within the medical device industry, monitoring worldwide regulatory developments and compliance issues. Mr. Desmarais will focus his efforts on leading Cybiocare’s compliance strategy in all vertical segments as the company continues to expand into new markets and grow the business on a worldwide basis.

Mr. Desmarais is a seasoned executive with over 30 years experience in the medical device industry. As Chief Scientific Officer at Cryocath Technologies he developed the regulatory and clinical strategies for an innovative Class III cardiovascular device for the treatment of cardiac arrhythmias. These strategies led to multiple IDE and pre-CE mark complex clinical trials. These trials culminated into several CE mark and PMA approvals. He led the first Canadian PMA approval of a therapeutic device. Most recently, he led the strategy and execution of the Arcic Front Stop-AF FDA land mark IDE multicenter trial. He completed enrolment that became the trigger for the company’s acquisition by Medtronic USA in Fall 2008. Mr. Desmarais has served on boards of device start-up companies in the fields of orthopedic (Biorthex) and cardiovascular devices (Cardianove LVAD). He also served on the board of BioSyntech (cartilage repair) as the industry expert to support their regulatory, clinical and compliance strategies.

"This is an ideal time to have Mr. Desmarais join Cybiocare. His experience and leadership in the medical device space will help take Cybiocare to the next level in the global medical device industry," said Michel Bédard, CEO of Cybiocare.